Genetic
1912 — Samuel A. K. Wilson's published monograph, United Kingdom
Wilson's disease was first formally described in the early twentieth century by a British neurologist who linked liver dysfunction to a distinctive neurological deterioration. For decades before its biochemical basis was understood, physicians struggled to classify it, often attributing its constellation of findings to separate, unrelated ailments. The condition's history became a landmark story in how inherited metabolic errors were gradually recognized and distinguished from infectious or degenerative diseases.
Historical Narrative
The earliest systematic clinical description of what would come to be called Wilson's disease appeared in 1912, when British neurologist Samuel Alexander Kinnier Wilson published his landmark doctoral thesis and subsequent paper titled 'Progressive Lenticular Degeneration: A Familial Nervous Disease Associated with Cirrhosis of the Liver.' Wilson meticulously documented a pattern of progressive neurological deterioration alongside severe liver damage in multiple members of the same families, and he correctly deduced that the condition was hereditary in nature. His monograph drew on postmortem examinations and careful clinical observation gathered over years, and it established that the lenticular nuclei of the brain — structures deep within the cerebral hemispheres — were consistently damaged in affected individuals. Before Wilson's synthesis, physicians had encountered similar patients but had categorized their presentations under various diagnoses, including forms of multiple sclerosis, juvenile paralysis agitans, or simple cirrhosis of unknown cause. There was no unified framework to connect the neurological and hepatic findings.
Following Wilson's publication, the condition bore his name, but the underlying mechanism remained mysterious for decades. In the 1930s and 1940s, researchers began suspecting that some kind of toxic accumulation was responsible for the tissue damage. A major breakthrough came when investigators, including John Nathaniel Cumings in Britain, demonstrated in 1948 that copper was deposited in abnormally high concentrations in the livers and brains of patients who had died with Wilson's disease. This finding redirected scientific attention toward copper metabolism as the central problem and transformed the condition from a neurological curiosity into a metabolic disorder.
Around the same time, the ophthalmologist Bernhard Kayser had described peculiar greenish-brown rings at the periphery of the cornea in 1902, and Bruno Fleischer had linked these corneal findings more specifically to Wilson's disease by 1903 and 1912. These rings, thereafter known as Kayser-Fleischer rings, became an important feature that physicians examined for during the early and mid-twentieth century when evaluating patients with unexplained neurological or hepatic disease, though clinicians of that era lacked the tools to confirm copper accumulation during life.
The hereditary nature of the condition was refined through pedigree analyses conducted across the mid-twentieth century. Researchers established that the pattern of inheritance was autosomal recessive, meaning that both parents had to carry the relevant trait for a child to develop the full condition. This understanding built on the growing science of Mendelian genetics being applied to human disease during the 1920s through 1950s.
The development of penicillamine as a chelating agent in the 1950s, pioneered largely by John Walshe at Cambridge, represented a pivotal moment in the condition's therapeutic history. Walshe demonstrated that penicillamine could bind copper in the body and facilitate its excretion, and early clinical reports from the late 1950s described patients whose neurological and hepatic deterioration halted or reversed under this treatment. The identification of the specific gene responsible, ATP7B, came much later in 1993, finally explaining why copper transport went awry at a molecular level and opening new avenues for understanding the condition's variable expression across affected families.
Key Historical Figures
Historical narrative only — this page describes how Wilson's disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.